20 studies found for:    Lundbeck and alzheimer's
Show Display Options
Rank Status Study
1 Recruiting A Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: Lu AF20513, low dose;   Biological: Lu AF20513, medium dose;   Biological: Lu AF20513, high dose
2 Recruiting Lu AE58054 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Drug: Lu AE58054
3 Recruiting Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Drug: Lu AE58054
4 Recruiting Lu AE58054 in Patients With Mild to Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Drug: Lu AE58054
5 Recruiting Long-term Safety and Tolerability of Lu AE58054 as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Lu AE58054 60 mg (or 30 mg)
6 Terminated
Has Results
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
7 Terminated
Has Results
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
8 Completed Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Lu AE58054;   Drug: Placebo
9 Completed
Has Results
A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
10 Completed Memantine for Agitation and Aggression in Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: memantine
11 Recruiting Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function
Condition: Alzheimer Disease
Intervention: Drug: Idalopirdine (Lu AE58054) 60 mg
12 Recruiting A Study of Two Fixed-doses of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Conditions: Agitation Associated With;   Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention: Drug: Brexpiprazole, OPC-34712
13 Recruiting Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Conditions: Agitation Associated With;   Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention: Drug: Brexpiprazole, OPC-34712
14 Unknown  Memantine on Aggression and Agitation of Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
15 Enrolling by invitation Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Conditions: Agitation Associated With Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention:
16 Completed
Has Results
Progression Delaying Effect of Escitalopram in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: escitalopram;   Drug: placebo
17 Completed Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
18 Unknown  Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer’s Disease, Vascular Dementia, and Mixed Vascular and Alzheimer’s Dementia
Condition: Depressive Syndrome
Intervention: Drug: Escitalopram
19 Completed Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia
Condition: Frontotemporal Dementia
Intervention: Drug: memantine hydrochloride
20 Completed Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Memantine (Ebixa);   Drug: riluzole;   Drug: Placebo

Indicates status has not been verified in more than two years